Dass-127

Once calculated, scores fall into five severity tiers:

| Severity | Depression | Anxiety | Stress | | :--- | :--- | :--- | :--- | | Normal | 0–9 | 0–7 | 0–14 | | Mild | 10–13 | 8–9 | 15–18 | | Moderate | 14–20 | 10–14 | 19–25 | | Severe | 21–27 | 15–19 | 26–33 | | Extremely Severe| 28+ | 20+ | 34+ | DASS-127

---

The synthesis of DASS-127 involved a multi-step process, starting with the condensation of 2-aminobenzothiazole with 2-bromo-5-nitrobenzoic acid, followed by reduction and subsequent modification to introduce the desired functional groups. The compound was then purified and characterized using NMR, IR, and mass spectrometry. Biological evaluation included in vitro assays for anti-inflammatory activity, such as inhibition of pro-inflammatory cytokine production (e.g., TNF-α, IL-6) and in vivo models of inflammation. Once calculated, scores fall into five severity tiers:

Participants rate each statement on a 4-point Likert scale: The synthesis of DASS-127 involved a multi-step process,

(Note: The standard DASS-21 requires you to multiply the final subscale scores by 2 to make them comparable to the original, longer 42-item DASS).

The results suggest that DASS-127 acts through a novel mechanism involving the modulation of inflammatory pathways. Its high efficacy and favorable safety profile make it an attractive candidate for further development.

“DASS-127” appears in zero public movie, game, book, or TV show databases (IMDb, ISFDB, Steam).

---